 |
市場調査レポート
商品コード
1452762
生体吸収性スキャフォールドの世界市場規模、シェア、成長分析、タイプ別、素材別 - 産業予測（2024～2031年）Global Bioresorbable Scaffolds Market Size, Share, Growth Analysis, By Type(Drug Eluting Coronary Scaffolds, Sirolimus-Eluting Device), By Material(Absorbable Magnesium Stent (AMS), Polymeric Scaffold) - Industry Forecast 2024-2031 |
||||||
| 生体吸収性スキャフォールドの世界市場規模、シェア、成長分析、タイプ別、素材別 - 産業予測（2024～2031年） |
|
出版日: 2024年03月09日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
生体吸収性スキャフォールドの世界市場規模は、2022年に3億7,494万米ドルと評価され、2023年の4億1,656万米ドルから2031年には9億6,692万米ドルに成長し、予測期間中（2024-2031年）のCAGRは11.10％で成長する見通しです。
生体吸収性スキャフォールド市場は、医療技術の進歩と心血管疾患の有病率の上昇に起因して大幅な成長を遂げています。これらのスキャフォールドは、冠動脈疾患の治療に利用される一時的なインプラントで、時間の経過とともに徐々に溶解し、血管の自然治癒を促進します。市場は材料タイプ、用途、エンドユーザー、地域別に分類されます。ポリマーベースのスキャフォールドは、その生体適合性と徐々に吸収されることから、材料タイプ別セグメントで優位を占めており、市場をリードしています。心臓血管疾患、整形外科疾患、その他を含む用途別セグメントでは、発生率の高さから心臓血管疾患が主な牽引役となっています。エンドユーザーには病院、外来手術センター、専門クリニックが含まれ、心臓インターベンションのための入院患者の増加がスキャフォールド需要を押し上げています。地域別では、北米が確立されたヘルスケア・インフラと心血管症例数の増加によって大きな市場シェアを占めています。欧州は研究開発に注力しており、アジア太平洋地域はヘルスケア投資の増加と高齢化により成長しています。市場促進要因としては、高齢者人口の増加、低侵襲手術の需要、技術の進歩などが挙げられます。しかし、高コストや熟練した専門家の必要性といった課題が市場拡大の妨げとなっています。スキャフォールドの特性や有効性を高めるための継続的な調査が、今後の生体吸収性スキャフォールド市場を牽引していくと予想されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
生体吸収性スキャフォールドの世界市場：タイプ別
- 市場概要
- 薬剤溶出性冠状動脈スキャフォールド
- シロリムス溶出装置
- エベロリムス溶出装置
- ノボリムス溶出装置
- パクリタキセル溶出装置
生体吸収性スキャフォールドの世界市場：素材別
- 市場概要
- 吸収性マグネシウムステント（AMS）
- ポリマースキャフォールド
- ポリカーボネートスキャフォールド
- その他
生体吸収性スキャフォールドの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Abbott
- Medtronic
- Boston Scientific Corporation
- Biotronik
- Elixir Medical Corporation
- REVA Medical
- Amaranth Medical
- Kyoto Medical Planning
- Xenogenics Corporation
- B. Braun
- Cardinal Health
- Lombard Medical
- Translumina
- MicroPort Scientific Corporation
- TERUMO CORPORATION
Global Bioresorbable Scaffolds Market size was valued at USD 374.94 million in 2022 and is poised to grow from USD 416.56 million in 2023 to USD 966.92 million by 2031, growing at a CAGR of 11.10% during the forecast period (2024-2031).
The bioresorbable scaffolds market is experiencing substantial growth attributed to advancements in medical technology and the rising prevalence of cardiovascular diseases. These scaffolds, temporary implants utilized for treating coronary artery diseases, gradually dissolve over time, facilitating natural vessel healing. The market is categorized by material type, application, end-user, and region. Polymer-based scaffolds, dominating the material type segment due to their biocompatibility and gradual resorption, lead the market. The application segment, encompassing cardiovascular diseases, orthopedic disorders, and others, sees cardiovascular diseases as the primary driver due to a high incidence rate. End-users include hospitals, ambulatory surgical centers, and specialized clinics, with increasing hospital admissions for cardiac interventions boosting scaffold demand. Geographically, North America holds a significant market share, driven by well-established healthcare infrastructure and a rising number of cardiovascular cases. Europe follows with a focus on research and development, while the Asia-Pacific region sees growth due to increased healthcare investments and an aging population. Market growth drivers include the growing elderly population, demand for minimally invasive procedures, and technological advancements. However, challenges such as high costs and the need for skilled professionals pose hindrances to market expansion. Ongoing research to enhance scaffold properties and efficacy is expected to drive the bioresorbable scaffolds market in the future.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Scaffolds Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioresorbable Scaffolds Market Segmental Analysis
The Bioresorbable Scaffolds market is segmented on the basis of disease type, treatment, end-user, and regional. Based on Disease Type the market is segmented as, Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO). Based on Treatment the market is segmented as, Anti-vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, And Others. Based on End-user the market is segmented as, Hospital & Clinics, Research and Academics, Others. Based on Regional the market is segmented as, North America, Asia Pacific, Latin America.
Drivers of the Global Bioresorbable Scaffolds Market
The increasing occurrence of cardiovascular diseases, including conditions like coronary artery disease and peripheral artery disease, plays a pivotal role in propelling the bioresorbable scaffolds market forward. To address these ailments and restore proper blood flow, there is a growing need for advanced treatments, fueling the demand for inventive solutions such as bioresorbable scaffolds.
Restraints in the Global Bioresorbable Scaffolds Market
The bioresorbable scaffolds market encounters a hurdle due to the scarcity of extensive long-term clinical data. The effectiveness and safety of bioresorbable scaffold implants relative to traditional stents require additional assessment for a conclusive understanding, emphasizing the need for further evaluation to establish their efficacy and safety over an extended period.
Market Trends of the Global Bioresorbable Scaffolds Market
The growing population of elderly individuals necessitates an increased frequency of healthcare services, leading to a rising demand for bioresorbable scaffolds. This is particularly crucial as older people tend to be more susceptible to cardiovascular diseases, highlighting the importance of advanced medical solutions to address their specific healthcare needs.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Bioresorbable Scaffolds Market by Type
- Market Overview
- Drug Eluting Coronary Scaffolds
- Sirolimus-Eluting Device
- Everolimus-Eluting Device
- Novolimus-Eluting Device
- and Paclitaxel-Eluting Device
Global Bioresorbable Scaffolds Market by Material
- Market Overview
- Absorbable Magnesium Stent (AMS)
- Polymeric Scaffold
- Polycarbonate Scaffold
- and Others
Global Bioresorbable Scaffolds Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elixir Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- REVA Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amaranth Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kyoto Medical Planning
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xenogenics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lombard Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Translumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TERUMO CORPORATION
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
